Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold

A novel class of SARS-CoV-2 main protease (M pro ) inhibitors derived from 1,5,6,7-tetrahydro-4 H -indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evalua...

Full description

Saved in:
Bibliographic Details
Published inMedicinal chemistry research Vol. 33; no. 1; pp. 151 - 163
Main Authors Piven, Yuri A., Zinovich, Veronica G., Shcherbakov, Dmitriy N., Chirkova, Varvara Yu, Belenkaya, Svetlana V., Puzanau, Raman M., Khlebnicova, Tatyana S., Lakhvich, Fedor A.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.01.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A novel class of SARS-CoV-2 main protease (M pro ) inhibitors derived from 1,5,6,7-tetrahydro-4 H -indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against M pro , two hits with IC 50 values bellow 60 μM were found with the best result of 27.31 μM for racemic amide 9m . SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy.
AbstractList A novel class of SARS-CoV-2 main protease (Mpro) inhibitors derived from 1,5,6,7-tetrahydro-4H-indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against Mpro, two hits with IC50 values bellow 60 μM were found with the best result of 27.31 μM for racemic amide 9m. SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy.
A novel class of SARS-CoV-2 main protease (M pro ) inhibitors derived from 1,5,6,7-tetrahydro-4 H -indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against M pro , two hits with IC 50 values bellow 60 μM were found with the best result of 27.31 μM for racemic amide 9m . SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy.
Author Belenkaya, Svetlana V.
Chirkova, Varvara Yu
Khlebnicova, Tatyana S.
Lakhvich, Fedor A.
Piven, Yuri A.
Zinovich, Veronica G.
Shcherbakov, Dmitriy N.
Puzanau, Raman M.
Author_xml – sequence: 1
  givenname: Yuri A.
  orcidid: 0000-0003-3640-0981
  surname: Piven
  fullname: Piven, Yuri A.
  email: piven.ya@gmail.com
  organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus
– sequence: 2
  givenname: Veronica G.
  surname: Zinovich
  fullname: Zinovich, Veronica G.
  organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus
– sequence: 3
  givenname: Dmitriy N.
  surname: Shcherbakov
  fullname: Shcherbakov, Dmitriy N.
  organization: Altay State University, State Research Center of Virology and Biotechnology “Vector”
– sequence: 4
  givenname: Varvara Yu
  surname: Chirkova
  fullname: Chirkova, Varvara Yu
  organization: Altay State University
– sequence: 5
  givenname: Svetlana V.
  surname: Belenkaya
  fullname: Belenkaya, Svetlana V.
  organization: State Research Center of Virology and Biotechnology “Vector”
– sequence: 6
  givenname: Raman M.
  surname: Puzanau
  fullname: Puzanau, Raman M.
  organization: Health Care Institution “National Anti-Doping Laboratory”
– sequence: 7
  givenname: Tatyana S.
  surname: Khlebnicova
  fullname: Khlebnicova, Tatyana S.
  organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus
– sequence: 8
  givenname: Fedor A.
  surname: Lakhvich
  fullname: Lakhvich, Fedor A.
  organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus
BookMark eNp9kEtLAzEUhYMo-PwDrgJuG81rXkspagVFsOo2ZCZJmzImNUmV9g_4t40dQXDh6p7F-e695xyCXeedBuCU4HOCcXURMcacI0wZwoxUHG12wAEpCo5qQvFu1jhrWlC2Dw5jXGDMKsyLA_A59q_LVdIBSau0gkpHO3MjGNcuzbOOUDoF9bvsVzJZ76A30OkPOL18nKKxf0EU3i-Dh9bNbWuTDxG2MuZF2UpGxagcVSjpFOR8rYJHfIKsU3Lje8RRjgBjJ43xvToGe0b2UZ_8zCPwfH31NJ6gu4eb2_HlHeoobxKqDC5My2vV6aasidFSadqxVkmjeF0zQ7UiVGluVNlQzmrMVVNIpjrCWkMrdgTOhr356beVjkks_Cq4fFLQhjBCqpqW2VUPri74GIM2orNpmz8nsb0gWHzXLobaRa5dbGsXm4zSP-gy2FcZ1v9DbIBiNruZDr9f_UN9AZaXmCM
CitedBy_id crossref_primary_10_17650_2313_805X_2024_11_4_54_65
Cites_doi 10.18097/PBMC20216703259
10.1111/febs.12936
10.1021/acs.jmedchem.0c01140
10.1182/blood-2008-04-151928
10.1016/j.softx.2015.06.001
10.1186/1756-0500-5-367
10.1002/jcc.21256
10.1126/science.1085658
10.1093/bioinformatics/btv082
10.1016/j.tetasy.2011.03.010
10.7150/ijbs.45472
10.1080/07391102.2021.1905559
10.1021/acsmedchemlett.0c00521
10.1021/acs.jmedchem.1c00598
10.1021/acs.chemrev.9b00055
10.1126/science.abl4784
10.1126/science.abb3405
10.1021/acs.jmedchem.1c01214
10.1039/d2md00344a
10.1016/j.bmc.2021.116521
10.1002/slct.201803469
10.1021/op300173z
10.1021/acsmedchemlett.1c00299
10.1021/acs.jctc.1c00645
10.1038/nrmicro.2016.81
10.1021/acsmedchemlett.2c00541
10.1186/1758-2946-3-33
10.1016/j.ejmech.2020.112711
10.1021/jp961710n
10.1021/acscentsci.1c00039
10.1021/ci500588j
10.1002/jmv.25681
10.1016/j.ejmech.2021.114046
10.1039/c5sc02678d
10.1021/jacs.1c08402
10.1073/pnas.2010470117
10.1016/j.steroids.2016.08.002
10.1016/j.molstruc.2022.133140
10.3390/v13020174
10.1002/wcms.1429
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
DBID AAYXX
CITATION
8FD
FR3
M7Z
P64
DOI 10.1007/s00044-023-03174-z
DatabaseName CrossRef
Technology Research Database
Engineering Research Database
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
DatabaseTitle CrossRef
Biochemistry Abstracts 1
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList Biochemistry Abstracts 1

DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1554-8120
EndPage 163
ExternalDocumentID 10_1007_s00044_023_03174_z
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
203
29M
29~
2J2
2JN
2JY
2KG
2LR
2VQ
2~H
30V
4.4
406
408
409
40D
40E
5GY
5VS
67N
67Z
6NX
78A
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFFNX
AFGCZ
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BAPOH
BDATZ
BGNMA
BSONS
CAG
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HLICF
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M4Y
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
PF0
PT4
QOR
QOS
R89
R9I
RIG
ROL
RPX
RSV
S16
S1Z
S27
S3A
S3B
SAP
SBL
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
YLTOR
Z45
Z7U
Z7V
Z87
ZMTXR
ZOVNA
~A9
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
8FD
ABRTQ
FR3
M7Z
P64
ID FETCH-LOGICAL-c249t-7f05fb48dce9681feade2c3bdafd4883f2ed12de4fd69243804d95a3dc13bf273
IEDL.DBID U2A
ISSN 1054-2523
IngestDate Tue Aug 12 22:14:40 EDT 2025
Tue Jul 01 01:53:36 EDT 2025
Thu Apr 24 22:57:13 EDT 2025
Fri Feb 21 02:41:35 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords indazol-4-ones
SARS-CoV-2
1, 5, 6, 7-Tetrahydro-4
Molecular dynamics
3CL
M
Molecular docking
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c249t-7f05fb48dce9681feade2c3bdafd4883f2ed12de4fd69243804d95a3dc13bf273
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0003-3640-0981
PQID 2913117826
PQPubID 2043723
PageCount 13
ParticipantIDs proquest_journals_2913117826
crossref_citationtrail_10_1007_s00044_023_03174_z
crossref_primary_10_1007_s00044_023_03174_z
springer_journals_10_1007_s00044_023_03174_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240100
2024-01-00
20240101
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 1
  year: 2024
  text: 20240100
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Heidelberg
PublicationTitle Medicinal chemistry research
PublicationTitleAbbrev Med Chem Res
PublicationYear 2024
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Wang, Sun, Wang, Wang, Liu, Zhang (CR24) 2019; 119
Shcherbakov, Baev, Kalinin, Dalinger, Chirkova, Belenkaya (CR13) 2022; 13
Okawa, Hideshima, Steed, Vallet, Hall, Huang (CR21) 2009; 113
Ye, Yuan, Yuen, Fung, Chan, Jin (CR2) 2020; 16
Stille, Tjutrins, Wang, Venegas, Hennecker, Rueda (CR11) 2022; 229
Andrianov, Nikolaev, Shuldov, Bosko, Anischenko, Tuzikov (CR33) 2022; 40
Liu, Liang, Xin, Ren, Tian, Ju (CR6) 2020; 206
Morris, Huey, Lindstrom, Sanner, Belew, Goodsell (CR37) 2009; 30
Sulimov, Shikhaliev, Pyankov, Shcherbakov, Chirkova, Ilin (CR34) 2021; 67
Sulur, Sharma, Ramakrishnan, Naidu, Merifield, Gill (CR22) 2012; 16
CR10
Piven, Yastrebova, Khamidullina, Scherbakov, Tatarskiy, Rusanova (CR32) 2022; 53
Anand, Ziebuhr, Wadhwani, Mesters, Hilgenfeld (CR4) 2003; 300
Alhossary, Handoko, Mu, Kwoh (CR23) 2015; 31
Muegge, Hu (CR25) 2023; 14
Strakova, Kumpiņa, Rjabovs, Lugiņina, Belyakov, Turks (CR29) 2011; 22
Valdes-Tresanco, Valdes-Tresanco, Valiente, Moreno (CR28) 2021; 17
O’Boyle, Banck, James, Morley, Vandermeersch, Hutchison (CR36) 2011; 3
Luttens, Gullberg, Abdurakhmanov, Vo, Akaberi, Talibov (CR19) 2022; 144
Hilgenfeld (CR5) 2014; 281
Chen, Liu, Guo (CR1) 2020; 92
Li, Li, Huang, Wu, Liu, Zhou (CR16) 2020; 117
Tian, Yue, Yang, Sang (CR30) 2019; 4
Chen, Gao, Liu, Li, Chen, Ma (CR15) 2023; 14
de Wit, van Doremalen, Falzarano, Munster (CR3) 2016; 14
Cannalire, Cerchia, Beccari, Di Leva, Summa (CR7) 2022; 65
Ghahremanpour, Tirado-Rives, Deshmukh, Ippolito, Zhang, Cabeza de Vaca (CR17) 2020; 11
Zhang, Stone, Deshmukh, Ippolito, Ghahremanpour, Tirado-Rives (CR18) 2021; 7
CR26
Owen, Allerton, Anderson, Aschenbrenner, Avery, Berritt (CR8) 2021; 374
Zhang, Lin, Sun, Curth, Drosten, Sauerhering (CR9) 2020; 368
Han, Goins, Arya, Shin, Maw, Hooper (CR12) 2022; 65
CR20
Hawkins, Cramer, Truhlar (CR39) 1996; 100
Abraham, Murtola, Schulz, Páll, Smith, Hess (CR27) 2015; 1-2
Aldeghi, Heifetz, Bodkin, Knapp, Biggin (CR40) 2016; 7
Sander, Freyss, von Korff, Rufener (CR35) 2015; 55
Ghosh, Raghavaiah, Shahabi, Yadav, Anson, Lendy (CR14) 2021; 64
Sousa da Silva, Vranken (CR38) 2012; 5
Khlebnicova, Piven, Baranovsky, Lakhvich, Shishkina, Zicane (CR31) 2017; 117
MM Ghahremanpour (3174_CR17) 2020; 11
R Cannalire (3174_CR7) 2022; 65
R Chen (3174_CR15) 2023; 14
ZW Ye (3174_CR2) 2020; 16
JK Stille (3174_CR11) 2022; 229
E de Wit (3174_CR3) 2016; 14
E Wang (3174_CR24) 2019; 119
YA Piven (3174_CR32) 2022; 53
J Tian (3174_CR30) 2019; 4
AW Sousa da Silva (3174_CR38) 2012; 5
GD Hawkins (3174_CR39) 1996; 100
A Alhossary (3174_CR23) 2015; 31
T Sander (3174_CR35) 2015; 55
MJ Abraham (3174_CR27) 2015; 1-2
L Zhang (3174_CR9) 2020; 368
I Muegge (3174_CR25) 2023; 14
A Luttens (3174_CR19) 2022; 144
D Shcherbakov (3174_CR13) 2022; 13
M Sulur (3174_CR22) 2012; 16
M Aldeghi (3174_CR40) 2016; 7
3174_CR10
Z Li (3174_CR16) 2020; 117
AK Ghosh (3174_CR14) 2021; 64
Y Liu (3174_CR6) 2020; 206
TS Khlebnicova (3174_CR31) 2017; 117
AV Sulimov (3174_CR34) 2021; 67
R Hilgenfeld (3174_CR5) 2014; 281
NM O’Boyle (3174_CR36) 2011; 3
CH Zhang (3174_CR18) 2021; 7
Y Chen (3174_CR1) 2020; 92
GM Morris (3174_CR37) 2009; 30
DR Owen (3174_CR8) 2021; 374
AM Andrianov (3174_CR33) 2022; 40
SH Han (3174_CR12) 2022; 65
I Strakova (3174_CR29) 2011; 22
MS Valdes-Tresanco (3174_CR28) 2021; 17
3174_CR20
Y Okawa (3174_CR21) 2009; 113
K Anand (3174_CR4) 2003; 300
3174_CR26
References_xml – volume: 67
  start-page: 259
  year: 2021
  end-page: 67
  ident: CR34
  article-title: Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease
  publication-title: Biomed Khim
  doi: 10.18097/PBMC20216703259
– volume: 281
  start-page: 4085
  year: 2014
  end-page: 96
  ident: CR5
  article-title: From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
  publication-title: FEBS J
  doi: 10.1111/febs.12936
– volume: 65
  start-page: 2716
  year: 2022
  end-page: 46
  ident: CR7
  article-title: Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.0c01140
– volume: 113
  start-page: 846
  year: 2009
  end-page: 55
  ident: CR21
  article-title: SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
  publication-title: Blood
  doi: 10.1182/blood-2008-04-151928
– volume: 1-2
  start-page: 19
  year: 2015
  end-page: 25
  ident: CR27
  article-title: GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers
  publication-title: SoftwareX
  doi: 10.1016/j.softx.2015.06.001
– volume: 5
  year: 2012
  ident: CR38
  article-title: ACPYPE – AnteChamber PYthon Parser interfacE
  publication-title: BMC Res Notes
  doi: 10.1186/1756-0500-5-367
– volume: 30
  start-page: 2785
  year: 2009
  end-page: 91
  ident: CR37
  article-title: AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility
  publication-title: J Comput Chem
  doi: 10.1002/jcc.21256
– volume: 300
  start-page: 1763
  year: 2003
  end-page: 7
  ident: CR4
  article-title: Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs
  publication-title: Science
  doi: 10.1126/science.1085658
– volume: 31
  start-page: 2214
  year: 2015
  end-page: 6
  ident: CR23
  article-title: Fast, accurate, and reliable molecular docking with QuickVina 2
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv082
– volume: 22
  start-page: 728
  year: 2011
  end-page: 39
  ident: CR29
  article-title: Resolution, absolute configuration, and synthetic transformations of 7-amino-tetrahydroindazolones
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2011.03.010
– volume: 16
  start-page: 1686
  year: 2020
  end-page: 97
  ident: CR2
  article-title: Zoonotic origins of human coronaviruses
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.45472
– volume: 40
  start-page: 7555
  year: 2022
  end-page: 73
  ident: CR33
  article-title: Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors
  publication-title: J Biomol Struct Dyn
  doi: 10.1080/07391102.2021.1905559
– ident: CR10
– volume: 11
  start-page: 2526
  year: 2020
  end-page: 33
  ident: CR17
  article-title: Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2
  publication-title: ACS Med Chem Lett
  doi: 10.1021/acsmedchemlett.0c00521
– volume: 65
  start-page: 2880
  year: 2022
  end-page: 904
  ident: CR12
  article-title: Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (SARS-CoV-2 3CL(pro))
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.1c00598
– volume: 119
  start-page: 9478
  year: 2019
  end-page: 508
  ident: CR24
  article-title: End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design
  publication-title: Chem Rev
  doi: 10.1021/acs.chemrev.9b00055
– volume: 374
  start-page: 1586
  year: 2021
  end-page: 93
  ident: CR8
  article-title: An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19
  publication-title: Science
  doi: 10.1126/science.abl4784
– volume: 368
  start-page: 409
  year: 2020
  end-page: 12
  ident: CR9
  article-title: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors
  publication-title: Science
  doi: 10.1126/science.abb3405
– volume: 64
  start-page: 14702
  year: 2021
  end-page: 14
  ident: CR14
  article-title: Indole chloropyridinyl ester-derived SARS-CoV-2 3CLpro inhibitors: enzyme inhibition, antiviral efficacy, structure-activity relationship, and X-ray structural studies
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.1c01214
– volume: 14
  start-page: 9
  year: 2023
  end-page: 21
  ident: CR15
  article-title: Advances in research on 3C-like protease (3CL(pro)) inhibitors against SARS-CoV-2 since 2020
  publication-title: RSC Med Chem
  doi: 10.1039/d2md00344a
– volume: 53
  start-page: 116521
  year: 2022
  ident: CR32
  article-title: Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2021.116521
– volume: 4
  start-page: 38
  year: 2019
  end-page: 41
  ident: CR30
  article-title: One-pot cleavage of aryl alkyl ethers by aluminum and iodine in acetonitrile
  publication-title: ChemistrySelect
  doi: 10.1002/slct.201803469
– volume: 16
  start-page: 1746
  year: 2012
  end-page: 53
  ident: CR22
  article-title: Development of scalable manufacturing routes to AZD1981. Application of the Semmler–Wolff aromatisation for synthesis of the indole-4-amide core
  publication-title: Org Process Res Dev
  doi: 10.1021/op300173z
– volume: 13
  start-page: 140
  year: 2022
  end-page: 7
  ident: CR13
  article-title: Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors
  publication-title: ACS Med Chem Lett
  doi: 10.1021/acsmedchemlett.1c00299
– volume: 17
  start-page: 6281
  year: 2021
  end-page: 91
  ident: CR28
  article-title: gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS
  publication-title: J Chem Theory Comput
  doi: 10.1021/acs.jctc.1c00645
– volume: 14
  start-page: 523
  year: 2016
  end-page: 34
  ident: CR3
  article-title: SARS and MERS: recent insights into emerging coronaviruses
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro.2016.81
– volume: 14
  start-page: 244
  year: 2023
  end-page: 50
  ident: CR25
  article-title: Recent advances in alchemical binding free energy calculations for drug discovery
  publication-title: ACS Med Chem Lett
  doi: 10.1021/acsmedchemlett.2c00541
– volume: 3
  start-page: 33
  year: 2011
  ident: CR36
  article-title: Open Babel: an open chemical toolbox
  publication-title: J Cheminform
  doi: 10.1186/1758-2946-3-33
– volume: 206
  start-page: 112711
  year: 2020
  ident: CR6
  article-title: The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2020.112711
– volume: 100
  start-page: 19824
  year: 1996
  end-page: 39
  ident: CR39
  article-title: Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium
  publication-title: J Phys Chem
  doi: 10.1021/jp961710n
– volume: 7
  start-page: 467
  year: 2021
  end-page: 75
  ident: CR18
  article-title: Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations
  publication-title: ACS Cent Sci
  doi: 10.1021/acscentsci.1c00039
– volume: 55
  start-page: 460
  year: 2015
  end-page: 73
  ident: CR35
  article-title: DataWarrior: an open-source program for chemistry aware data visualization and analysis
  publication-title: J Chem Inf Model
  doi: 10.1021/ci500588j
– volume: 92
  start-page: 418
  year: 2020
  end-page: 23
  ident: CR1
  article-title: Emerging coronaviruses: genome structure, replication, and pathogenesis
  publication-title: J Med Virol
  doi: 10.1002/jmv.25681
– volume: 229
  start-page: 114046
  year: 2022
  ident: CR11
  article-title: Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL(pro) covalent inhibitors
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2021.114046
– volume: 7
  start-page: 207
  year: 2016
  end-page: 18
  ident: CR40
  article-title: Accurate calculation of the absolute free energy of binding for drug molecules
  publication-title: Chem Sci
  doi: 10.1039/c5sc02678d
– volume: 144
  start-page: 2905
  year: 2022
  end-page: 20
  ident: CR19
  article-title: Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.1c08402
– volume: 117
  start-page: 27381
  year: 2020
  end-page: 7
  ident: CR16
  article-title: Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2010470117
– ident: CR26
– volume: 117
  start-page: 77
  year: 2017
  end-page: 89
  ident: CR31
  article-title: Synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage
  publication-title: Steroids
  doi: 10.1016/j.steroids.2016.08.002
– ident: CR20
– volume: 65
  start-page: 2716
  year: 2022
  ident: 3174_CR7
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.0c01140
– volume: 3
  start-page: 33
  year: 2011
  ident: 3174_CR36
  publication-title: J Cheminform
  doi: 10.1186/1758-2946-3-33
– volume: 281
  start-page: 4085
  year: 2014
  ident: 3174_CR5
  publication-title: FEBS J
  doi: 10.1111/febs.12936
– volume: 7
  start-page: 467
  year: 2021
  ident: 3174_CR18
  publication-title: ACS Cent Sci
  doi: 10.1021/acscentsci.1c00039
– volume: 14
  start-page: 244
  year: 2023
  ident: 3174_CR25
  publication-title: ACS Med Chem Lett
  doi: 10.1021/acsmedchemlett.2c00541
– volume: 368
  start-page: 409
  year: 2020
  ident: 3174_CR9
  publication-title: Science
  doi: 10.1126/science.abb3405
– volume: 55
  start-page: 460
  year: 2015
  ident: 3174_CR35
  publication-title: J Chem Inf Model
  doi: 10.1021/ci500588j
– volume: 40
  start-page: 7555
  year: 2022
  ident: 3174_CR33
  publication-title: J Biomol Struct Dyn
  doi: 10.1080/07391102.2021.1905559
– volume: 17
  start-page: 6281
  year: 2021
  ident: 3174_CR28
  publication-title: J Chem Theory Comput
  doi: 10.1021/acs.jctc.1c00645
– volume: 206
  start-page: 112711
  year: 2020
  ident: 3174_CR6
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2020.112711
– volume: 31
  start-page: 2214
  year: 2015
  ident: 3174_CR23
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv082
– volume: 117
  start-page: 77
  year: 2017
  ident: 3174_CR31
  publication-title: Steroids
  doi: 10.1016/j.steroids.2016.08.002
– volume: 14
  start-page: 9
  year: 2023
  ident: 3174_CR15
  publication-title: RSC Med Chem
  doi: 10.1039/d2md00344a
– volume: 11
  start-page: 2526
  year: 2020
  ident: 3174_CR17
  publication-title: ACS Med Chem Lett
  doi: 10.1021/acsmedchemlett.0c00521
– volume: 67
  start-page: 259
  year: 2021
  ident: 3174_CR34
  publication-title: Biomed Khim
  doi: 10.18097/PBMC20216703259
– volume: 1-2
  start-page: 19
  year: 2015
  ident: 3174_CR27
  publication-title: SoftwareX
  doi: 10.1016/j.softx.2015.06.001
– volume: 13
  start-page: 140
  year: 2022
  ident: 3174_CR13
  publication-title: ACS Med Chem Lett
  doi: 10.1021/acsmedchemlett.1c00299
– volume: 53
  start-page: 116521
  year: 2022
  ident: 3174_CR32
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2021.116521
– volume: 30
  start-page: 2785
  year: 2009
  ident: 3174_CR37
  publication-title: J Comput Chem
  doi: 10.1002/jcc.21256
– volume: 14
  start-page: 523
  year: 2016
  ident: 3174_CR3
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro.2016.81
– ident: 3174_CR20
  doi: 10.1016/j.molstruc.2022.133140
– volume: 16
  start-page: 1746
  year: 2012
  ident: 3174_CR22
  publication-title: Org Process Res Dev
  doi: 10.1021/op300173z
– volume: 100
  start-page: 19824
  year: 1996
  ident: 3174_CR39
  publication-title: J Phys Chem
  doi: 10.1021/jp961710n
– volume: 22
  start-page: 728
  year: 2011
  ident: 3174_CR29
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2011.03.010
– volume: 113
  start-page: 846
  year: 2009
  ident: 3174_CR21
  publication-title: Blood
  doi: 10.1182/blood-2008-04-151928
– volume: 64
  start-page: 14702
  year: 2021
  ident: 3174_CR14
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.1c01214
– volume: 300
  start-page: 1763
  year: 2003
  ident: 3174_CR4
  publication-title: Science
  doi: 10.1126/science.1085658
– volume: 119
  start-page: 9478
  year: 2019
  ident: 3174_CR24
  publication-title: Chem Rev
  doi: 10.1021/acs.chemrev.9b00055
– ident: 3174_CR10
  doi: 10.3390/v13020174
– volume: 4
  start-page: 38
  year: 2019
  ident: 3174_CR30
  publication-title: ChemistrySelect
  doi: 10.1002/slct.201803469
– volume: 5
  year: 2012
  ident: 3174_CR38
  publication-title: BMC Res Notes
  doi: 10.1186/1756-0500-5-367
– volume: 117
  start-page: 27381
  year: 2020
  ident: 3174_CR16
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2010470117
– volume: 92
  start-page: 418
  year: 2020
  ident: 3174_CR1
  publication-title: J Med Virol
  doi: 10.1002/jmv.25681
– volume: 7
  start-page: 207
  year: 2016
  ident: 3174_CR40
  publication-title: Chem Sci
  doi: 10.1039/c5sc02678d
– volume: 16
  start-page: 1686
  year: 2020
  ident: 3174_CR2
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.45472
– volume: 374
  start-page: 1586
  year: 2021
  ident: 3174_CR8
  publication-title: Science
  doi: 10.1126/science.abl4784
– ident: 3174_CR26
  doi: 10.1002/wcms.1429
– volume: 229
  start-page: 114046
  year: 2022
  ident: 3174_CR11
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2021.114046
– volume: 65
  start-page: 2880
  year: 2022
  ident: 3174_CR12
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.1c00598
– volume: 144
  start-page: 2905
  year: 2022
  ident: 3174_CR19
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.1c08402
SSID ssj0037045
Score 2.3144162
Snippet A novel class of SARS-CoV-2 main protease (M pro ) inhibitors derived from 1,5,6,7-tetrahydro-4 H -indazol-4-ones was designed. Virtual screening based on...
A novel class of SARS-CoV-2 main protease (Mpro) inhibitors derived from 1,5,6,7-tetrahydro-4H-indazol-4-ones was designed. Virtual screening based on...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 151
SubjectTerms Biochemistry
Biomedical and Life Sciences
Biomedicine
Bioorganic Chemistry
CAD
Computer aided design
Inorganic Chemistry
Mathematical analysis
Medicinal Chemistry
Molecular docking
Molecular dynamics
Original Research Article
Pharmacology/Toxicology
Protease inhibitors
Proteinase inhibitors
Severe acute respiratory syndrome coronavirus 2
Synthesis
Title Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold
URI https://link.springer.com/article/10.1007/s00044-023-03174-z
https://www.proquest.com/docview/2913117826
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9swDBW29rphn1i6ruCh6GUmENuSIx_TolnQokWxNkN3MmxTwgIE9lB7h-QP7G-PUuwYG7YBPflgWTZMiXwUyUchjimMypKRNyZSKWQtaZHtuEZlLRUUGpsXzlG8uk7mC3lxr-67orCmz3bvQ5JeU--K3XzwEdnGIC_EicTNU7Gv2Hd3iVyLaNrr33gy9q2JGThIjNjP6kpl_j7H7-ZowJh_hEW9tZm9EM87mAjTrVxfiiemeiVObrY80-sA7oayqSaAE7gZGKjXr8XPvlcDOgJIAvJpGgE064rxXrNsIK8IBqJvqC0wvIbb6edbPKu_YARX_JGwrL4ti6XrxwPO2hHw0DBQQRJMsDUt66k1PdQo5-g8-029Qol1ZaApc2vrFb0Ri9n53dkcu44LWLIb1uLEjpUtpKbSpIkOrcumjsq4oNwS7_TYRoaFS0ZaSthxi_VYUqrymMowLiwjobdir-L3vBOQxibRVjNAK4xMtdJkGVlYbXwkMQ5HIux_fFZ2dOSuK8Yq2xEpe2FlLKzMCyvbjMTH3TPft2Qc_x192Msz6zZmk0Wp4xdiWJSMRNDLeLj979kOHjf8vXjGS5PBbBRuD2wOxV778MN8YAjTFkdifzo7Pb12109fL8-P_Ar-BTG_6js
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VcoBLRfkRS0vxAXohI20cJ-scOKwK1ZZ2q4ruot5CEttipVVSNalQ9gV4ER6UsTfZCARIHHqO41iZ8cw39sw3AK-Vz_OckDdGIgyRrKRB8uMSQ2NUpnxt0swGitPzaDIXH6_Cqy340dXCuGz37krSWepNsZu7fETyMUiKOBK4alMpT3XzjQK16t3Je5LqG86PP8yOJtj2EsCcAowaR2YYmkxIles4kr6xecI8DzKVGkU6HBiuadlKC6MiCkkCORQqDtNA5X6QGfLxNO89uE_gQ9q9M-fjzt4Ho6FrhUxARSCnuK4tzfnzmn91fz2m_e0a1nm340ew08JSNl7r0S5s6eIxHF6sea0bj836Mq3KY4fsome8bp7A9643BFrCScWUSwvxWNUUhC-rRcXSQrGeWJyVhhGcZ5fjT5d4VH5Gzqa0SLYovi6yhe3_w6x3VYyG-l7oRd4Ia12TXWzUTYligvYkYVUuUWBZaFblqTHlUj2F-Z1I5RlsF_Sd58DiQEfSSAKEmRaxDKUyhGSM1O7mMvAH4Hc_Pslb-nPbhWOZbIibnbASElbihJWsBvB28871mvzjn6P3O3kmrSGoEh5bPiOCYdEAvE7G_eO_z_bi_4a_ggeT2fQsOTs5P92Dh5yg1_qgaB-265tb_ZKgU50dOM1l8OWut8pP4kElmg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkRAXVP7EQgEfoBcy6sZxss6Bw6pltaW0WtEu6i0ksUddaZVUTVCVfQFeh0dk7E02AgESh57jOD8z9nzjmfmGsTfaF3lOyBsiGYZAuyQC2XEFIaLOtG8wzayjeHIaTefy40V4scV-dLUwLtu9C0muaxosS1NR719p3N8UvrlAJJC9AVLKkYRVm1Z5bJobctqq90eHJOG3Qkw-nB9Moe0rADk5GzWMcBhiJpXOTRwpH23OsMiDTKeoSZ8DFIY-QRuJOiL3JFBDqeMwDXTuBxmSvad577C70lYf0wqai3G39wejoWuLTKBFgiAfry3T-fM7_2oKe3z7W0jWWbrJDnvQQlQ-XuvUQ7Zlikdsb7bmuG48ft6XbFUe3-Oznv26ecy-d30iwJJPaq5diojHq6YgrFktKp4Wmvck47xETtCen40_n8FB-QUEP6GX5IvicpEtbC8gbi2t5jTU90Iv8kZQm5r2yEZflyCnYE8VVuUSJJSF4VWeIpZL_YTNb0UqT9l2Qc95xngcmEihInCYGRmrUGkkVIPKuChm4A-Y3_34JG-p0G1HjmWyIXF2wkpIWIkTVrIasHebe67WRCD_HL3byTNpN4UqEbHlNiJIFg2Y18m4v_z32Z7_3_DX7N7scJJ8Ojo9fsHuC0Jh9szIF7tsu77-Zl4SiqqzV05xOft62yvlJ8_wKc8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Computer-aided+design%2C+synthesis+and+evaluation+of+new+SARS-CoV-2+Mpro+inhibitors+based+on+1%2C5%2C6%2C7-tetrahydro-4H-indazol-4-one+scaffold&rft.jtitle=Medicinal+chemistry+research&rft.au=Piven%2C+Yuri+A.&rft.au=Zinovich%2C+Veronica+G.&rft.au=Shcherbakov%2C+Dmitriy+N.&rft.au=Chirkova%2C+Varvara+Yu&rft.date=2024-01-01&rft.issn=1054-2523&rft.eissn=1554-8120&rft.volume=33&rft.issue=1&rft.spage=151&rft.epage=163&rft_id=info:doi/10.1007%2Fs00044-023-03174-z&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00044_023_03174_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1054-2523&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1054-2523&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1054-2523&client=summon